| Ticker | KROS |
|---|---|
| ISIN | US4923271013 |
| Sector | Atención sanitaria |
| Mercado | NASDAQ |
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia in patients with myelodysplastic syndromes, and in pa...
El precio actual de Keros Therapeutics, Inc. (KROS) es de 11,51 , con una variación del -0,43%.
Keros Therapeutics, Inc. opera en el sector Healthcare, industria Biotechnology.
Compara brokers con acceso a las principales bolsas internacionales, con bajas comisiones, custodia y herramientas de análisis para invertir en acciones.
Compara brokers para acciones